Company Filing History:
Years Active: 2021
Title: The Innovations of Patrick L Chow
Introduction
Patrick L Chow is a notable inventor based in Lawrenceville, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of cancer treatment methods. His work has led to the creation of innovative solutions that enhance the efficacy of existing therapies.
Latest Patents
One of Patrick L Chow's key patents is titled "Method of preparing fluorine-18 labeled Cabozantinib and its analogs." This invention relates to a method of preparing Cabozantinib, a compound that plays a crucial role in cancer treatment. The patent highlights the process of labeling Cabozantinib with fluorine-18, which is essential for imaging and therapeutic applications. Patrick holds 1 patent in this area, showcasing his expertise and dedication to advancing medical science.
Career Highlights
Patrick L Chow is currently associated with Exelixis, Inc., a company known for its focus on developing innovative cancer therapies. His role at Exelixis allows him to work on cutting-edge research that aims to improve patient outcomes. His contributions to the field have been recognized by peers and industry leaders alike.
Collaborations
Throughout his career, Patrick has collaborated with esteemed colleagues such as Wei Xu and David J Donnelly. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the advancement of research in oncology.
Conclusion
Patrick L Chow's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the development of Cabozantinib, highlight the importance of research and collaboration in creating effective cancer treatments. His ongoing efforts continue to inspire advancements in medical science.